Streetbeat News

Stock Prices

NFLX

Netflix reported Q4 sales that exceeded expectations and a 12.8% increase in global streaming paid memberships compared to the previous year, leading to a rise in its stock price.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:32 pm

NFLX

Wedbush analyst Michael Pachter has maintained an Outperform rating on Netflix (NASDAQ:NFLX) and increased the price target from $525 to $615, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:31 pm

SLNH

Soluna Holdings, Inc. (NASDAQ:SLNH) has reduced its convertible debt by over $4M and plans a capital raise for a new AI venture. The company has made progress on its green data center projects, including Project Dorothy and Project Kati, and has signed a new 8.8 MW customer for Project Sophie. Soluna's data centers have been found to have an 18% lower carbon footprint than traditional data centers. Operational metrics and project updates were provided, with a focus on installed hashrate, power capacity, and energy consumption.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:29 pm

CBRL

LEG

WHR

The article highlights three consumer discretionary stocks with high dividend yields, as rated by Wall Street's most accurate analysts according to Benzinga's Analyst Stock Ratings. Leggett & Platt (LEG) has a dividend yield of 7.75% but faces a restructuring plan and workforce reduction. Cracker Barrel (CBRL) offers a 6.89% yield but reported worse-than-expected Q1 results. Whirlpool (WHR) has a 6.27% yield and plans to sell part of its stake in Whirlpool India in 2024.

Portfolio Pulse from Avi Kapoor

January 24, 2024 | 1:29 pm

SFNC

Simmons First National Corporation (SFNC) reported Q4 sales of $177.60 million, which fell short of the expected $204.25 million estimate.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:20 pm

VLN

Valens Semiconductor (NYSE:VLN) introduced the VA700R Series, enhancing long vehicle sensor connectivity with 4Gbps bandwidth over 40 meters. The VA700R Series, including the VA7021R Serializer and VA7004R Deserializer, supports high-resolution cameras and ADAS applications. Demonstrations are available, with engineering samples expected in mid-2024. The technology addresses visibility challenges for long vehicles and has garnered significant interest, with a demonstration at Automotive World Japan.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:20 pm

BLFY

Blue Foundry (NASDAQ:BLFY) reported Q4 EPS of $(0.13), surpassing the $(0.15) estimate, and sales of $9.77M, exceeding the $9.55M estimate. However, these figures represent a significant decrease from the previous year, with a 750% drop in EPS from $0.02 and a 26.95% decline in sales from $13.37M.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:20 pm

PLUG

Plug Power Inc. (NASDAQ:PLUG) shares dropped over 5% in premarket trading on Wednesday after a 31% surge the previous day. The decline follows Truist Securities analyst Jordan Levy reiterating a Hold rating and halving the price target from $6 to $3, citing long-term visibility concerns and reducing FY25E revenues. Despite Plug Power announcing the start of operations at the largest U.S. liquid green hydrogen plant, the company faces challenges, including a significant year-over-year share price drop and supply issues in its hydrogen network.

Portfolio Pulse from Nabaparna Bhattacharya

January 24, 2024 | 1:19 pm

PRPL

Wedbush analyst Seth Basham has reiterated an Outperform rating on Purple Innovation (NASDAQ:PRPL) and maintained a price target of $1.25.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:19 pm

STVN

Stevanato Group S.p.A. (NYSE:STVN) has launched the EZ-fill Kit and a non-GMP laboratory fill and finish service to support small batch drug development and commercialization. The EZ-fill Kit, part of Stevanato's ready-to-use platform, offers customizable solutions for injectables, which make up over 60% of drugs in development. The kit will be available in Q2 2024 and will be showcased at Pharmapack. The non-GMP service at the Technology Excellence Centers in the USA and Italy helps customers assess fill-and-finish process effects early on. These offerings aim to improve drug manufacturing standards and speed up market entry for new biopharmaceuticals.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 1:17 pm